Familial Cold Autoinflammatory Syndrome (FCAS)
Also known as: Familial Cold Autoinflam Syn (FCAS) / Familial Cold Autoinflammatory Syndromes / Familial Cold Urticaria / Familial Cold Auto-inflammatory Syndrome / Familial Cold Autoinflammatory Syndrome / Cryopyrin-associated periodic syndromes / FCAS / Familial cold urticaria (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06168 | Canakinumab | An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). |
DB06372 | Rilonacept | An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06168 | Canakinumab | Interleukin-1 beta | target |
DB06372 | Rilonacept | Interleukin-1 beta | target |
DB06372 | Rilonacept | Interleukin-1 alpha | target |
DB06372 | Rilonacept | Interleukin-1 receptor antagonist protein | target |